Improved survival shown in early-stage Hodgkin’s disease patients who receive radiation therapy

15 septiembre 2014

Patients with stage I and II Hodgkin’s Disease who receive consolidated radiation therapy (RT) have a higher 10-year survival rate of 84 percent, compared to 76 percent for patients who did not receive RT; and, the data also shows a decrease in utilization of RT, according to new research.